Cargando…
MEK inhibitors and their potential in the treatment of advanced melanoma: the advantages of combination therapy
The treatment of melanoma has improved markedly over the last several years with the advent of more targeted therapies. Unfortunately, complex compensation mechanisms, such as those of the mitogen-activated protein kinase (MAPK) pathway, have limited the clinical benefit of these treatments. Recentl...
Autores principales: | Tran, Khiem A, Cheng, Michelle Y, Mitra, Anupam, Ogawa, Hiromi, Shi, Vivian Y, Olney, Laura P, Kloxin, April M, Maverakis, Emanual |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694671/ https://www.ncbi.nlm.nih.gov/pubmed/26730180 http://dx.doi.org/10.2147/DDDT.S93545 |
Ejemplares similares
-
Risk factors for MEK-associated retinopathy in patients with advanced melanoma treated with combination BRAF and MEK inhibitor therapy
por: Booth, Andrew E. C., et al.
Publicado: (2020) -
Treatment of melanoma in-transit metastases with combination intralesional interleukin-2, topical imiquimod, and tretinoin 0.1% cream
por: Leventhal, Jonathan S., et al.
Publicado: (2016) -
Integrating BRAF/MEK inhibitors into combination therapy for melanoma
por: Smalley, K S M, et al.
Publicado: (2009) -
Combined Immune Checkpoint Blockade and Stereotactic Ablative Radiotherapy Can Stimulate Response to Immunotherapy in Metastatic Melanoma: A Case Report
por: Moran, Angel, et al.
Publicado: (2019) -
Red Light Phototherapy Using Light-Emitting Diodes Inhibits Melanoma Proliferation and Alters Tumor Microenvironments
por: Austin, Evan, et al.
Publicado: (2022)